Wall Street pulled back slightly Tuesday as investors locked in profits following a string of record-setting gains and turned their focus to the Federal Reserve's closely watched policy meeting.The S&P 500 edged down 0.13% to close at 6,606.76 after touching a fresh intraday record earlier in the session. The Nasdaq Composite slipped 0.07% to 22,333.96, while the Dow Jones Industrial Average lost 125.55 points, or 0.27%, to end at 45,757.90.Market leaders that powered much of this year's rally were under pr ...

Search fieldEntering text into the input field will update the search result belowEntering text into the input field will update the search result below ...

Major indexes are trading just under record highs. ...

Switzerland-based food and beverage giant Nestlé on Tuesday announced that its chairman, Paul Bulcke, has decided to step down and will be replaced by former Inditex CEO Pablo Isla from October 1 onwards.“The Board of Directors of Nestlé S.A. has announced that Pablo Isla will become Chairman effective October 1, following Paul Bulcke's decision to step down from the Board earlier than planned,” the company said in a release.His resignation comes two weeks after Laurent Freixe was dismissed as CEO due to an ...

Topline The Food and Drug Administration sent warning letters to dozens of drug companies— including popular telehealth firm Hims & Hers and pharmaceutical giants Eli Lilly and Novo Nordisk— demanding they correct “false or misleading claims” about some of their popular weight-loss products after President Donald Trump signed an order designed to clamp down on drug advertising.The letters were issued a week ago. (Photo by Sarah Silbiger/Getty Images)Getty ImagesKey FactsThe warning letters were sent to over ...

Federal Reserve Chairman Jerome Powell speaks at Jackson Hole on Aug. 22, 2025 in Wyoming.David A. Grogan | CNBCThe Federal Reserve meets this week with some big items on the agenda: An important rate decision and forecast of what's ahead, combined with a healthy dose of political intrigue uncommon for central bank policymakers.On the monetary side, the Federal Open Market Committee on Wednesday will release its ruling on where it will set the overnight borrowing rate. Along with that, officials will sketch ...

PresentationGuido OelkersCEO & President Hello, everyone. This is Guido Oelkers, CEO of Sobi. We are delighted to welcome you to this call to discuss the NASP program after we have just received the acceptance of the filing package with FDA for uncontrolled gout. Please turn to Slide 2. We would like to remind you of the usual provisions on statements about expectations and projections of future events. With this said, please turn to Slide 3. I'm very pleased to have Dr. Herbert Baraf joining us today. He i ...

Question-and-Answer SessionUnknown Analyst So as always, we go through some questions, and then we'll open up for Q&A in the last 15 minutes or so, depending on how we get on. But why don't we start from where we left things, which is you posted almost 20% RoTE in the first half of the year. You've confirmed that this metric is going to be around 22% on average over the next 3 years, '25 to '28. And maybe we can start with your views on the outlook for the group, and you've presented a new outlook also on t ...

CHARLOTTE, N.C., Sept. 16, 2025 /PRNewswire/ -- Honeywell (NASDAQ: HON) today announced that, in connection with the previously announced spin-off (the "Spin-Off") of Solstice Advanced Materials Inc. ("Solstice") from Honeywell, Solstice has priced a private offering of $1 billion aggregate principal amount of senior notes due 2033 (the "Notes"). The Notes will be issued at par, bear interest at a rate of 5.625% per annum, payable semi-annually in arrears on March 31 and September 30 of each year, beginning ...

NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between May 12, 2022 and September 22, 2022, both dates inclusive (the “Class Period”), of the important September 24, 2025 lead plaintiff deadline. The lead plaintiff process was reopened by the Court. SO WHAT: If you purchased Spectrum Pharmaceuticals common stock during the Class Period you may be entitled to compensation ...